Search result
Unlocking Therapeutic Antibody Strategies against Human Cytomegalovirus
Institution: Institut für Virologie – Labor für Infektions- und Immunbiologie, University Hospital Cologne
Applicant: Matthias Zehner
ForTra: Funding of up to €100,000 for regulatory consulting costs
ForTra gGmbH für Forschungstransfer der Else Kröner-Fresenius-Stiftung (ForTra), finances strategic advice provided by consulting firms to prepare and conduct orientation and scientific advice meetings with regulatory authorities for the planning and approval of clinical trials (‘pre-IND meetings’).
Synthesis of an antimicrobial peptide analogue under GMP conditions for a clinical trial in ulcerative colitis
Institution: Medizinische Klinik 1, Universitätsklinikum Erlangen
Applicant: Sebastian Zundler
GMP-production of GO102, a novel anti-fibrotic molecule
Institution: University Medical Center Göttingen (UMG)
Applicant: Prof. Dr. Michael Zeisberg
Precision-RNA: a scalable platform of patient-customized, programmable oligonucleotide treatments for brain diseases
Institution: Division Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, Center of Neurology, University Hospital Tübingen
Applicant: Matthis Synofzik
Innovative antibodies against antibiotic-resistant Pseudomonas aeruginosa bacteria
Institution: Klinik I für Innere Medizin, Uniklinik Köln
Antragsteller: Prof. Dr. Dr. Jan Rybniker, Dr. Alexander Simonis